Another coronavirus vaccine candidate close to approval process. Johnson & Johnson vaccine could help speed up the rollout.
- Johnson & Johnson finishes trials for single-dose COVD vaccine | Connect the Dots ( Download)
- Johnson and Johnson Vaccine - Interim Results For Phase 1 and 2 ( Download)
- Johnson & Johnson one dose vaccine sees immune response in early trials ( Download)
- Johnson & Johnson expects to report trial data next week for one dose vaccine ( Download)
- Johnson & Johnson COVID vaccine could be approved soon ( Download)
- Connect the Dots: Another COVID-19 vaccine ( Download)
- Coronavirus vaccine: Johnson & Johnson says one-dose vaccine is 72% effective in U.S. ( Download)
- Johnson & Johnson’s 1-shot COVID-19 vaccine shows promise in early-stage trials ( Download)
- Why are health experts excited about the Johnson & Johnson COVID-19 vaccine trial ( Download)
- Single dose Johnson & Johnson COVID-19 vaccine could help rural communities ( Download)
- Johnson and Johnson says 1-shot vaccine shows promising results in early trial | WNT ( Download)
- How the Johnson & Johnson COVD-19 vaccine is different from the others ( Download)
- Johnson & Johnson says single-dose COVID-19 vaccine will be a 'game-changer' ( Download)
- Johnson & Johnson Covid-19 vaccine is 66% effective in global trial ( Download)
- Johnson & Johnson Confident on Covid Vaccine Trial Despite Pause: CFO ( Download)
